Precipitation strengthening and reversed yield stress asymmetry in Mg alloys containing rare-earth elements: A quantitative study

AbstractThe effect of prismatic plates on the mechanical behaviour at low and high temperature of a Mg-1 wt.% Mn- 1 wt%Nd alloy was determined. For this purpose, a weakly textured extruded bar, exhibiting similar values for the critical resolved shear stresses of the various deformation systems, was annealed at 275 °C for different time periods. During these thermal treatments the grain size and texture remained invariant, but different precipitate distributions, characterised by transmission electron microscopy (TEM), were generated. The as-extruded and the annealed material were tested under tension and compression at room temperature (RT) and 250 °C along the extrusion direction. Precipitation was observed to harden the alloy at RT and to induce a reversed yield stress (YS) asymmetry, the compressive YS being higher than the tensile YS. At 250 °C, the alloy is anomalously resistant under compressive conditions, exhibiting an enhanced reversed YS asymmetry. In order to assess the strengthening effect of particles on the individual major Mg deformation systems, appropriate versions of the Orowan equation were developed. The correlation of the predicted results with the experimental data revealed that reversed YS asymmetry at RT is attributable to a strong promotion of prismatic slip over twinning. Finally, experimental observations by TEM suggested that reversed YS asymmetry at high temperature arises from a different interaction of pyramidal <c+a> dislocations with particles and solutes in tension and compression

Evolution of the microstructure, texture and creep properties of the 7075 aluminium alloy during hot accumulative roll bonding

The 7075 Al alloy was severely deformed at 350 °C by a 3:1 thickness reduction per pass accumulative roll bonding (ARB) process up to six passes. It was found that discontinuous recrystallisation occurs during the inter-pass annealing stages from the third pass on, attributable to the increment of the mean particle size during processing. As a consequence, the mean crystallite size did not decrease, but remained approximately constant at 440 nm along the present ARB process and the mean boundary misorientation angle reached a maximum of 30° for the 3-passes sample. However, since nucleation of new grains takes place at the pre-existing grain boundaries, discontinuous recrystallisation results in slight changes in texture throughout the processing, being the orientations in the ARBed samples predominantly located along the typical rolling β-fibre. Uniaxial tests conducted at 300 °C and 350 °C revealed that the operating deformation mechanism in the processed alloy at such temperatures was grain boundary sliding; the optimum superplastic strain rate being 3×10−3–10−2 s−1. Boundary misorientation and thermal stability are the two main factors that contribute to high elongations to failureFinancial support from the CICYT (Projects MAT2009-14452 and MAT2012-38962)Peer reviewe

Effect of rare earth additions on the critical resolved shear stresses of magnesium alloys

An inverse optimization strategy based on crystal plasticity finite element simulations of polycrystals was used to obtain the critical resolved shear stresses of two Mg?1%Mn alloys containing neodymium from macroscopic experimental data. It was found that, with respect to pure Mg, the presence of Nd increases the CRSSbasal, CRSStwinning, and the CRSSbasal/CRSStwinning ratio and decreases the CRSSnon-basal/CRSStwinning ratio. Additions of neodymium as high as 1 wt% result in similar CRSSs values for all deformation modes and, thus, in an isotropic yielding behavior

Mg–1Zn–1Ca alloy for biomedical applications. Influence of the secondary phases on the mechanical and corrosion behaviour

An as-cast Mg–1Zn–1Ca alloy has been soundly characterized to be used as a biodegradable material in biomedical applications. Ca and Zn additions have a great influence in the microstructure, mechanical properties and corrosion behaviour of Mg alloys. SEM examinations revealed that most of the Ca and Zn atoms form Mg2Ca and Ca2Mg6Zn3 precipitates, which distribute preferentially along the grain boundaries forming a continuous network of secondary phases. The results of nanoindentation tests show differences in hardness and elastic modulus between the α-Mg matrix and the secondary phases. The results of three-point bending tests shows that cracks propagate following the network formed by the intermetallic compounds at the grain boundaries (GBs). The evolved hydrogen after immersion in Hank’s solution of the alloy has been also estimated, showing a change in the corrosion mechanism after 160 h. The intermetallic compounds act as a barrier against corrosion, so that it progresses through the α-Mg matrix phase

Impact of a Primary Care Antimicrobial Stewardship Program on Bacterial Resistance Control and Ecological Imprint in Urinary Tract Infections

Antimicrobial stewardship programs (ASPs) are a central component in reducing the overprescription of unnecessary antibiotics, with multiple studies showing benefits in the reduction of bacterial resistance. Less commonly, ASPs have been performed in outpatient settings, but there is a lack of available data in these settings. We implemented an ASP in a large regional outpatient setting to assess its feasibility and effectiveness. Over a 5-year post-implementation period, compared to the pre-intervention period, a significant reduction in antibiotic prescription occurred, with a reduction in resistance in E. coli urinary isolates. ASP activities also were found to be cost-effective, with a reduction in medication prescription

The European Solar Telescope

The European Solar Telescope (EST) is a project aimed at studying the magnetic connectivity of the solar atmosphere, from the deep photosphere to the upper chromosphere. Its design combines the knowledge and expertise gathered by the European solar physics community during the construction and operation of state-of-the-art solar telescopes operating in visible and near-infrared wavelengths: the Swedish 1m Solar Telescope, the German Vacuum Tower Telescope and GREGOR, the French Télescope Héliographique pour l'Étude du Magnétisme et des Instabilités Solaires, and the Dutch Open Telescope. With its 4.2 m primary mirror and an open configuration, EST will become the most powerful European ground-based facility to study the Sun in the coming decades in the visible and near-infrared bands. EST uses the most innovative technological advances: the first adaptive secondary mirror ever used in a solar telescope, a complex multi-conjugate adaptive optics with deformable mirrors that form part of the optical design in a natural way, a polarimetrically compensated telescope design that eliminates the complex temporal variation and wavelength dependence of the telescope Mueller matrix, and an instrument suite containing several (etalon-based) tunable imaging spectropolarimeters and several integral field unit spectropolarimeters. This publication summarises some fundamental science questions that can be addressed with the telescope, together with a complete description of its major subsystems

Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

Background: This study provides a global overview of the management of patients with acute cholecystitis during the initial phase of the COVID-19 pandemic. Methods: CHOLECOVID is an international, multicentre, observational comparative study of patients admitted to hospital with acute cholecystitis during the COVID-19 pandemic. Data on management were collected for a 2-month study interval coincident with the WHO declaration of the SARS-CoV-2 pandemic and compared with an equivalent pre-pandemic time interval. Mediation analysis examined the influence of SARS-COV-2 infection on 30-day mortality. Results: This study collected data on 9783 patients with acute cholecystitis admitted to 247 hospitals across the world. The pandemic was associated with reduced availability of surgical workforce and operating facilities globally, a significant shift to worse severity of disease, and increased use of conservative management. There was a reduction (both absolute and proportionate) in the number of patients undergoing cholecystectomy from 3095 patients (56.2 per cent) pre-pandemic to 1998 patients (46.2 per cent) during the pandemic but there was no difference in 30-day all-cause mortality after cholecystectomy comparing the pre-pandemic interval with the pandemic (13 patients (0.4 per cent) pre-pandemic to 13 patients (0.6 per cent) pandemic; P = 0.355). In mediation analysis, an admission with acute cholecystitis during the pandemic was associated with a non-significant increased risk of death (OR 1.29, 95 per cent c.i. 0.93 to 1.79, P = 0.121). Conclusion: CHOLECOVID provides a unique overview of the treatment of patients with cholecystitis across the globe during the first months of the SARS-CoV-2 pandemic. The study highlights the need for system resilience in retention of elective surgical activity. Cholecystectomy was associated with a low risk of mortality and deferral of treatment results in an increase in avoidable morbidity that represents the non-COVID cost of this pandemic

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p&lt;0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (&lt;1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (&lt;1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

The European Solar Telescope

The European Solar Telescope (EST) is a project aimed at studying the magnetic connectivity of the solar atmosphere, from the deep photosphere to the upper chromosphere. Its design combines the knowledge and expertise gathered by the European solar physics community during the construction and operation of state-of-the-art solar telescopes operating in visible and near-infrared wavelengths: the Swedish 1m Solar Telescope, the German Vacuum Tower Telescope and GREGOR, the French Télescope Héliographique pour l’Étude du Magnétisme et des Instabilités Solaires, and the Dutch Open Telescope. With its 4.2 m primary mirror and an open configuration, EST will become the most powerful European ground-based facility to study the Sun in the coming decades in the visible and near-infrared bands. EST uses the most innovative technological advances: the first adaptive secondary mirror ever used in a solar telescope, a complex multi-conjugate adaptive optics with deformable mirrors that form part of the optical design in a natural way, a polarimetrically compensated telescope design that eliminates the complex temporal variation and wavelength dependence of the telescope Mueller matrix, and an instrument suite containing several (etalon-based) tunable imaging spectropolarimeters and several integral field unit spectropolarimeters. This publication summarises some fundamental science questions that can be addressed with the telescope, together with a complete description of its major subsystems